AUROLIFE PHARMA LLC FDA Approval ANDA 088726

ANDA 088726

AUROLIFE PHARMA LLC

FDA Drug Application

Application #088726

Application Sponsors

ANDA 088726AUROLIFE PHARMA LLC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL250MG0CHLORPROPAMIDECHLORPROPAMIDE

FDA Submissions

ORIG1AP1984-08-31
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1985-09-24
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1986-03-13
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1986-08-08
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1986-08-08
MANUF (CMC); Manufacturing (CMC)SUPPL7AP1986-08-08
LABELING; LabelingSUPPL13AP1988-01-27
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1994-12-30

Submissions Property Types

SUPPL2Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL15Null0
SUPPL16Null0

CDER Filings

AUROLIFE PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88726
            [companyName] => AUROLIFE PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CHLORPROPAMIDE","activeIngredients":"CHLORPROPAMIDE","strength":"250MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CHLORPROPAMIDE","submission":"CHLORPROPAMIDE","actionType":"250MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.